Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1364-1368

  Morris Jr , J Glenn ^a   Sztein, Marcelo B ^b   Rice, Eugene W ^b   Nataro, James P ^b   Losonsky, Genevieve A ^b   Panigrahi, Pinaki ^b   Tacket, Carol O ^b   Johnson, Judith A ^b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CELL AGGREGATION; CHOLERA; DIARRHEA; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; PHENOTYPE; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; VIBRIO CHOLERAE;

EID: 0029847421     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1364     Document Type: Article

References (16)

1. White PB. The rugose variant of vibrios. J Pathol Bacteriol 1938;46:1-6.
2. White PB. The characteristic hapten and antigen of rugose races of cholera and El Tor vibrios. J Pathol Bacteriol 1940;50:160-4.
3. White PB. A note on the globular forms of Vibrio cholerae.J Gen Microbiol 1950;4:36-7.
4. Rice EW, Johnson CH, Clark RM, et al. Vibrio cholerae O1 can assume a "rugose" survival form that resists killing by chlorine, yet retains virulence. Int J Environ Health Res 1993;3:89-98.
5. Levine MM, Black RE, Clements ML, Nalin DR, Cisneros L, Finkelstein RA. Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli; a review. In: Home T, Holmgren J, Merson MH, Mollby R, eds. Acute enteric infections in children. New prospects for treatment and prevention. Amsterdam: Elsevier/North-Holland Biomedical Press, 1981:443-59.
6. Morris JG Jr, Takeda T, Tall BD, et al. Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest 1990;85:697-705.
7. Hall RH, Vial PA, Kaper JB, Mekalanos JJ, Levine MM. Morphological studies on fimbriae expressed by Vibrio cholerae O1. Microb Pathog 1988;4:257-65.
8. American Public Health Association. Standard methods for the examination of water and wastewater, 17th ed. Washington, DC: APHA, 1989.
9. Johnson JA, Panigrahi P, Morris JG Jr. Non-Ol Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun 1992;60:684-9.
10. Morris JG Jr, Losonsky GE, Johnson JA, et al. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis 1995;171:903-8.
11. Levine MM, Young CR, Black RE, Takeda Y, Finkelstein RA. Enzymelinked immunosorbent assay to measure antibodies to purified heatlabile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin; application in serodiagnosis and seroepidemiology. J Clin Microbiol 1985;21:174-9.
12. Marshall KC. Biofilms: an overview of bacterial adhesion, activity, and control at surfaces. ASM News 1992;58:202-7.
13. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995;8:48-86.
14. Barua D. Laboratory diagnosis of cholera. In: Barua D, Burrows W, eds. Cholera. Philadelphia: WB Saunders, 1974:85-126.
15. Sack RB, Miller CE. Progressive changes of vibrio serotypes in germ-free mice infected with V. cholerae. J Bacteriol 1969;99:688-95.
16. Deb BC, Sircar BK, Sengupta PG, et al. Studies on interventions to prevent El Tor cholera transmission in urban slums. Bull WHO 1986;64:127-131.